Sun Pharmaceutical Industries Ltd.

The sales for the March 2025 quarter moved up 27.43% to Rs. 71857.40 millions as compared to Rs. 56391.40 millions during the corresponding quarter last year.The Total revenue for the quarter ended March 2025 of  Rs. 20004.60  millions  grew by 130.57% from Rs. 8676.00 millions.The company reported a good operating profit of 31214.60 millions compared to 20124.10 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202503	202403	% Var	202503	202403	% Var	202503	202403	% Var
Sales	71857.40	56391.40	27.43	230033.30	202751.70	13.46	230033.30	202751.70	13.46
Other Income	3638.10	1188.80	206.03	6239.70	4657.60	33.97	6239.70	4657.60	33.97
PBIDT	31214.60	20124.10	55.11	71620.50	60533.70	18.32	71620.50	60533.70	18.32
Interest	2174.20	2175.90	-0.08	8932.10	7840.80	13.92	8932.10	7840.80	13.92
PBDT	29040.40	17948.20	61.80	62688.40	50502.70	24.13	62688.40	50502.70	24.13
Depreciation	2919.60	3930.40	-25.72	12382.70	16006.20	-22.64	12382.70	16006.20	-22.64
PBT	26120.80	14017.80	86.34	50305.70	34496.50	45.83	50305.70	34496.50	45.83
TAX	6116.20	5341.80	14.50	7479.50	5914.70	26.46	7479.50	5914.70	26.46
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	20004.60	8676.00	130.57	42826.20	28581.80	49.84	42826.20	28581.80	49.84
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	43.44	35.69	21.73	31.13	29.86	4.28	31.13	29.86	4.28